Wisconsin Administrative Code

CSB 2.94 Addition of seven (7) synthetic benzimidazole-opioid substances to schedule I. (1) Section 961.14 (2) (mm) and (pe), Stats., are renumbered to 961.14 (2) (xm) 3. and 5. and amended to read: 961.14 (2) (xm) 3. Etonitazene (2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol1-yl…

CSB 2.95 Addition of Ganaxolone to schedule V. Section 961.22 (11), Stats., is created to read: 961.22 (11) GANAXOLONE. Ganaxolone. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; (title) created under s. 13.92 (4) (b…

CSB 2.96 Addition of Amineptine to schedule I. Section 961.14 (7) (r), Stats., is created to read: 961.14 (7) (r) 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid, commonly known as Amineptine. History: cr. Affirmative action order under s. 961.11 (4), Stats…

CSB 2.97 Addition of Zipeprol to schedule I. Section 961.14 (2) (zm), Stats., is created to read: 961.14 (2) (zm) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin1-yl]-1-phenylpropan-2-ol). History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Mar…

CSB 2.98 Excluding [18F]FP-CIT from schedule II. Section 961.16 (2) (b), Stats., is amended to read: 961.16 (2) (b) Coca leaves and any salt, compound, derivative, or preparation of coca leaves. Decocainized coca leaves or extractions which do not contain cocaine or ecgonine are …

CSB 2.99 Addition of Mesocarb to schedule I. Section 961.14 (7) (s), Stats., is created to read: the chapter was last published.

CSB 3.01 Authority. The provisions in this chapter are adopted under the authority in s. 961.335 (8), Stats.

CSB 3.02 Definitions. In this chapter: (1) XBoardY means the controlled substances board. (2) XControlled substanceY has the meaning given in s. 961.01 (4), Stats. (3) XHumane shelterY means a facility that is intended to provide for and promote the welfare, protection, shelter, …

CSB 3.03 Permits generally. (1) No individual may manufacture, obtain, possess, use, administer, or dispense a controlled substance for a special use without a valid SUA permit for such purpose. (2) An SUA permit may be issued to an individual only. (2m) A SUA permit may be issue…

CSB 3.04 SUA permit application. (1) Every applicant for an SUA permit shall: (a) Submit a completed application. A complete application shall include a detailed description of the anticipated uses for each identified controlled substance in Schedules I to V of ch. 961, Stats., i…

CSB 3.042 Storage. (1) Individuals holding a SUA permit shall store controlled substances in a safe or steel cabinet or box that meets all of the following requirements: (a) Bolted or cemented to the floor or wall in such a way that it cannot be readily removed if the safe or ste…

CSB 3.045 Limited special use authorization. The board may grant a limited SUA permit or deny a SUA permit 2 based upon consideration of public health and safety including any of the following reasons: (1) An act constituting a violation under s. CSB 3.08 (1). (2) Making any mate…

CSB 3.05 Limitations on narcotic dog trainer drugs and drug quantities. (1) Narcotic dog trainers shall be limited to having possession of the following drugs and quantities at any given time during the permit period: (a) Up to 2 kilograms of marijuana. Marijuana may require peri…

CSB 3.06 Amendment. (1) A SUA permit shall be effective only for the individual, substances, and project specified on its face and for additional projects which derive directly from the state project. An individual holding a valid SUA permit may apply for an amendment to the perm…

CSB 3.07 Record-keeping; records retention; disclosure. (1) A SUA permit holder shall maintain updated and accurate records of all of the following: the chapter was last published. 3 CONTROLLED SUBSTANCES BOARD (a) The purchase of controlled substances pursuant to the SUA permit,…

CSB 3.08 Violations. (1) The following acts shall constitute a violation of an SUA permit: (a) Any deviation from the SUA permit[s specifications re- CSB 3.08 lated to controlled substances, schedules of drugs, or amounts authorized. (b) Failure to comply with this chapter or s. …

CSB 4.01 Authority and scope. The rules in this chapter are adopted under authority in ss. 227.11 (2) (a) and 961.385, Stats., for the purpose of creating a prescription drug monitoring program to collect and disclose information relating to the prescribing and dispensing of moni…

CSB 4.02 Definitions. As used in this chapter: (1) “Access” means to have the ability to view monitored prescription drug history reports, audit trails, and PDMP data as authorized by s. CSB 4.09. (2) “Administer” has the meaning given in s. 961.385 (1) (a), Stats. (2m) “Agent” h…

CSB 4.03 Drugs that have a substantial potential for abuse. Pursuant to s. 961.385 (1) (ag), Stats., the board has identified all of the following drugs as having a substantial potential for abuse: (1) A controlled substance identified in schedule II, III, IV or V in the federal …

CSB 4.04 Compilation of dispensing data. (1) As used in this section, “NDC number” means national drug code number, the universal product identifier used in the U.S. to identify a specific drug product. (2) Subject to s. CSB 4.08, a dispenser shall compile dispensing data that co…

CSB 4.05 Electronic submission of dispensing data. (1) Unless exempt under s. CSB 4.08, a dispenser shall electronically submit dispensing data to the PDMP in any of the following ways: (a) As a file that complies with the data standards identified in version 4 and release 2 of A…

CSB 4.06 Frequency of submissions. (1) A dispenser shall submit dispensing data to the PDMP no later than 11:59 p.m. of the next business day after the monitored prescription drug is dispensed. (2) If a dispenser does not dispense a monitored prescription drug on a business day, …

CSB 4.07 Correction of dispensing data. (1) A dispenser shall electronically correct dispensing data in the PDMP system within 5 business days of discovering an omission, error, or inaccuracy in previously submitted dispensing data. (2) The board may refer a dispenser and dispens…

CSB 4.08 Exemptions from compiling and submitting dispensing data. (1) The board shall exempt a dispenser from compiling and submitting dispensing data and from submitting a zero report as required under this chapter until the dispenser is required to renew its license, or until …

CSB 4.093 Monitored prescription drug history reports and audit trails about healthcare professionals. (1) Healthcare professionals may access audit trails about themselves and their practitioner delegates or pharmacist delegates. (2) A practitioner may access the audit trails ac…

CSB 4.097 Deny, suspend, revoke or otherwise restrict or limit access. (1) The board may deny, suspend, revoke, or otherwise restrict or limit a healthcare professional’s, pharmacist delegate’s, practitioner delegate’s, or medical coordinator’s access to monitored prescription dr…

CSB 4.10 Requests for review. (1) A dispenser, healthcare professional, pharmacist delegate, practitioner delegate, or medical coordinator may request that the board review any of the following: (b) The denial of an emergency waiver requested pursuant to s. CSB 4.06 (3). (c) The …

CSB 4.105 Practitioners’ requirement to review monitored prescription drug history reports. (1) A practitioner, or a practitioner delegate assisting the practitioner in accordance with the standards of practice for the practitioner’s profession, shall review the monitored prescri…

CSB 4.11 Methods of obtaining monitored prescription drug history reports. (1) The board shall disclose the monitored prescription drug history report about a patient to the patient if he or she does all of the following: (a) Appears in person at the department with two forms of …

CSB 4.12 Use of PDMP data by the board and department. (1) The board shall develop and maintain a PDMP database to store dispensing data and PDMP data in a secure environment and an encrypted format. (2m) The board shall develop and maintain a PDMP system to facilitate all of the…

CSB 4.13 Confidentiality of PDMP records. (1) The dispensing data, PDMP data, audit trails, monitored prescription drug history reports, and prescribing metrics reports maintained, created, or stored as a part of the program are not subject to inspection or copying under s. 19.35…

CSB 4.14 Exchange of PDMP data. (1) The board may exchange monitored prescription drug history reports and PDMP data with a prescription monitoring program operated by a relevant agency in another state or jurisdiction if the prescription monitoring program satisfies all of the f…

CSB 4.15 Disclosure of suspicious or critically dangerous conduct or practices. (1) The board may review dispensing data, monitored prescription drug history reports, PDMP data, and data compiled pursuant to s. CSB 4.12 to determine whether circumstances indicate suspicious or cr…

CVRB 1.01 Purpose. The purpose of this chapter is to establish procedures for the review of complaints made to the crime victims rights board. This chapter interprets the provisions of ss. 950.09 and 950.095, Stats., and also interprets the provisions of ch. 227, Stats., concerni…

CVRB 1.02 Definitions. In this chapter: (1) XBoardY means the crime victims rights board. (2) XChairpersonY means the chairperson of the board. (3) XComplainantY means the individual filing a complaint with the board. (4) XComplaintY means a written, sworn complaint made to the b…

CVRB 1.03 Delegation of responsibilities. The board may delegate its responsibilities in ss. CVRB 1.05 to 1.07 to an appropriate designee. History: Cr. Register, June, 2000, No. 534, eff. 7-1-00.

CVRB 1.04 Filing. (1) All written statements of a party[s position submitted to the board, including the complaint and the answer, shall be signed by the person preparing the statement. A party shall verify that the contents of each filing submitted by that party or on that party…

CVRB 1.05 Probable cause determination. (1) Upon receipt of the complaint, the board shall contact the mediator and request verification that the substance of the complaint has been presented to the department and that the department has completed its action as required by ss. 95…

CVRB 1.06 Investigations. (1) The board may conduct an investigation of any complaint which meets the probable cause standards under this chapter. The board may request responses to written questions, participation in a personal or telephonic interview with the board, and written…

CVRB 1.07 Hearings. (1) A hearing may be requested by any party or by the board. A party may appear in person or by telephone at the hearing, or may submit a written statement of position on the complaint in place of a personal appearance. (2) A party who chooses not to appear at…

CVRB 1.08 Decisions. (1) At the close of the hearing, the board shall meet for purposes of deliberating on the complaint. Upon a vote of the board, the board may deliberate in closed session as provided by s. 19.85 (1) (a), Stats. (2) Within 30 days of the close of the hearing, o…

CVRB 1.09 Rehearing. (1) A party aggrieved by the final decision may file a written request for rehearing with the board within 20 days after the date of the final decision. (2) The request for rehearing shall include a detailed statement of the grounds for the request, including…

CVRB 1.10 Judicial review. Judicial review of the board[s final decision is governed by ss. 227.52 to 227.59, Stats. History: Cr. Register, June, 2000, No. 534, eff. 7-1-00. the chapter was last published.

CVRB 1.11 Miscellaneous provisions. (1) RELIEF FROM DEADLINES. The board may grant a party[s request for reasonable extension of the deadlines set forth in this chapter. (2) REPRESENTATION. A party may be represented throughout proceedings under this chapter, including at hearing…

Chir 1.01 Authority. The rules in chs. Chir 1 to 13 are adopted under the authority of ss. 15.08 (5) (b), 227.11 (2) and ch. 446, Stats. History: Cr. Register, December, 1984, No. 348, eff. 1-1-85; correction made

Chir 1.02 Definitions. As used in chs. Chir 1 to 13: (1) XBoardY means the chiropractic examining board. (1m) XCurrent proficiency in the use of an automated external defibrillatorY means that a person has successfully completed a course of instruction in the use of an automated …

Chir 10.01 Definitions. In this chapter: (1) XAdjunctive servicesY means services which are preparatory or complementary to the practice of chiropractic. XAdjunctive servicesY include the taking and preparation of a preliminary patient history and providing physiotherapy treatmen…

Chir 10.015 Chiropractic technician course of study. The board shall grant certification as a chiropractic technician to an applicant who satisfies the requirements under s. 446.026 (2) (a), Stats. The course of study required under s. 446.026 (2) (a) 3., Stats., shall be one of …

Chir 10.02 Delegation of adjunctive services to a chiropractic technician. A chiropractor may delegate the performance of an adjunctive service to a chiropractic technician if all of the following conditions are met: (1) The chiropractor maintains records or ensures the chiroprac…

Chir 10.023 Delegation of adjunctive services to a health care professional. A chiropractor may delegate the performance of an adjunctive service to a health care professional if all of the following conditions are met: (1) The performance of the adjunctive service is within the …